Animal Clinical Chemistry

Embed Size (px)

Citation preview

  • 8/9/2019 Animal Clinical Chemistry

    1/231

  • 8/9/2019 Animal Clinical Chemistry

    2/231

    Animal Clinical Che

    A Primer for Toxicologist

  • 8/9/2019 Animal Clinical Chemistry

    3/231

    Animal Clinical ChA Primer for Toxicologist

    Edited by

    G.O.EVANS

  • 8/9/2019 Animal Clinical Chemistry

    4/231

    This edition published in the Taylor & Francis e-

    To purchase your own copy of this or any of Taylor & Francis

    thousands of eBooks please go to http://www.ebook

    UKTaylor & Francis Ltd, 1 Gunpowder Square, Lo

    USATaylor & Francis Inc., 1900 Frost Road, Suite 10

    Copyright Taylor & Francis Ltd 19

    All rights reserved. No part of this publication may be reproduced

    transmitted, in any form or by any means, electronic, electrostat

    photocopying, recording or otherwise, without the prior permis

    British Library Cataloguing in Publication Data A catalogue

    from the British Library

  • 8/9/2019 Animal Clinical Chemistry

    5/231

    Contents

    Preface

  • 8/9/2019 Animal Clinical Chemistry

    6/231

    Abbreviations

    Appendix I SI Units and Conversion Tables

    Appendix II General References for Animal Clinical Che

    Index

  • 8/9/2019 Animal Clinical Chemistry

    7/231

    Preface

    In 1975 clinical chemists from several pharmaceutic

  • 8/9/2019 Animal Clinical Chemistry

    8/231

    Contributors

    D T DAVIES

  • 8/9/2019 Animal Clinical Chemistry

    9/231

    1

    General Introductio

    C O EVANS

  • 8/9/2019 Animal Clinical Chemistry

    10/231

    For food additives, often with low biological activity, the

    demonstrate a no observable adverse effect level (NOAEto identify separately any changes in data which may b

    response to repeated overdosage. This is in contrast to the si

    important to both demonstrate potential toxic response an

    effect level (NOEL): here the difficulties are in distingu

    pharmacological response(s), desired pharmacological actio

    apparent toxic effect(s) (James, 1993). It remains debatab

    should be based on demonstrating the absence of toxic stoxicity (Heywood, 1981). Toxicology studies are generally

    adverse effects of a xenobiotic by identifying its effects

    metabolic functions, and furthermore to determine if these e

    f h d d i i l i i

    Animal clinical chemistry 2

  • 8/9/2019 Animal Clinical Chemistry

    11/231

    When the toxicity of chemical mixtures is under exam

    data becomes more difficult: a mixture of two or more chemqualitative or quantitative response relative to that predicte

    exposure to the mixture constituents. For example, the co-

    hepatotoxic compounds, carbon tetrachloride and 1,2

    expected to show an additive effect on plasma alanine amin

    the resultant dual exposure reduces the degree of liver injur

    to the effects produced by 1,2-dichlorobenzene alone (Mum

    pretreatment of rats with retinol potentiates the hepatoassociated plasma ALT with carbon tetrachloride (ElSisi et a

    Polypharmacy may complicate toxic changes, and a

    associated with inactive ingredients in drug formulations (

    hi l d f d d li k dl ff i

    General introduction 3

  • 8/9/2019 Animal Clinical Chemistry

    12/231

    Animal clinical chemistry 4

  • 8/9/2019 Animal Clinical Chemistry

    13/231

    Table 1.1Definitions of test spec

    sensitivitySensitivityof an assay is the fraction of those with a specific diseas

    predicts.

    Specificityis the fraction of those without the disease that the assay

    Where

    TP=True positive, number of affected individuals correctly

    FP=False positive, number of non-affected individuals mi

    FN=False negative, number of affected individuals miscla

    General introduction 5

  • 8/9/2019 Animal Clinical Chemistry

    14/231

    The total variance for a single measurement may be expre

    variance + biological variance + methodological (or study) these three components. In later chapters, we discuss some

    approach the statistical analysis of the data.

    Few if any of the common laboratory tests are intrinsica

    most tests requiring some decision as to where to select the

    and abnormality. Effective interpretation involves conside

    probability values, it requires knowledge and experience

    Clinical pathology measurements should always be interpother study data obtained from histopathology, experimenta

    simple example is plasma or urine osmolality where water

    mass should be collectively considered for the correct interp

    Animal clinical chemistry 6

  • 8/9/2019 Animal Clinical Chemistry

    15/231

    instrumentation and commercially available high-quality re

    has been reduced, so that intra-batch coefficient of variatioachievable for most of the common tests. It is usually a lit

    and manual tests. Thus as a general rule, analytical variance

    the biological variance in the total variance sum. Wherev

    changes during studies should be avoided.

    The number of tests (or parameters) determined in a stud

    size and the analytical methodology available, although

    require small sample volumes for most of the common teststest). It is sometimes suggested that the choice of biochemi

    been governed by investigators more familiar with human

    has led to the inclusion of tests which are inappropriate for

    S h f il i h l f h

    General introduction 7

  • 8/9/2019 Animal Clinical Chemistry

    16/231

    of sample collection and separation procedures, and w

    collection tube systems are currently designed for collectinthose usually obtained with smaller laboratory animals.

    disinfecting or autoclaving biological waste materials, an

    analysers prior to selective maintenance procedures should b

    1.5Summary

    Biochemical measurements can help in:

    Identifying target organ toxicity. Confirmation of other observations particularly changes fo

    Animal clinical chemistry 8

  • 8/9/2019 Animal Clinical Chemistry

    17/231

    EVANS, G.O. (1994) Removal of blood from laboratory mammals28, 1789.

    FLETCHER, A.P. (1978) Drug safety tests and subsequent clinicalRoyal Society of Medicine,71,6936.

    GLOCKLIN, V.C. (1983) The role of data organisation in the eval

    drug application.Drug Information Journal,13951.

    GOLIGHTLY, L.K., SMOLINSKE, S.S., BENNETT, M.L., SUTHB.H. (1988) Pharmaceutical excipients. Adverse effects associa

    drug products.Medical Toxicology,3,20940.

    GRANDJEAN, P., BROWN, S.S., REAVEY, P. & YOUNG, D.S.chemical exposure. The proceedings of the Arnold O.Beckman/Environmental Toxicology. Clinical Chemistry,40,1359476.

    GRINER, P.F., MAYEWSKI, R.J., MUSHLIN, A.I. & GREENLA

    interpretation of diagnostic tests and procedures Annals of Inte

    General introduction 9

  • 8/9/2019 Animal Clinical Chemistry

    18/231

    2

    Study Design and Regul

    Requirements

  • 8/9/2019 Animal Clinical Chemistry

    19/231

    animals per group are also usually defined. For sub-acute ro

    females per group are appropriate with double this number rodent studies (usually with dogs), four animals of each

    sufficient for most regulatory studies. There are no clear g

    animals that should be bled at each time-point but, conventi

    be bled while 20 rodents (10 males and 10 females) per gro

    Similarly, the frequency of blood sampling is left entirely to

    or study director. As a minimum, blood samples should be c

    For mice, where limitation of blood volume makes interimsamples can only reliably be collected at necropsy. Multi

    jugular or cephalic veins is clearly not a problem in the lar

    rat, several acceptable sites of interim blood sampling are de

    l d h i d h l l b i fl

    Study design and regulatory requirement

  • 8/9/2019 Animal Clinical Chemistry

    20/231

    livephase of a sub-chronic study, when pathological evalua

    exploit the strengths of clinical pathology and provide add

    of value. A blood-sampling regimen, similar to that descradopted provided that the sampling does not compromise the

    This view is further supported by Davies (1992) who de

    blood samples can provide valuable information on the

    pathology. In the experiment described, blood samples take

    study had normal plasma alkaline phosphatase (ALP) an

    (AST) activities but there was a slight increase in alanactivity; morphologically the liver was normal. Early blood

    1 and 2 exhibited elevated ALP and ALT activities and the

    showed more than a 20-fold increase compared to the pre-

    l i d f l k b d i i d

    Animal clinical chemistry 12

  • 8/9/2019 Animal Clinical Chemistry

    21/231

    Table 2.1Pre-clinical blood chem

    regulatory documents

    Glucose* Inorganic

    Urea (or urea nitrogen)* Urate*

    Creatinine* Cholester

    Aspartate aminotransferase* Lactate dAlanine aminotransferase* Total pro

    Total bilirubin* Albumin*

    Study design and regulatory requirement

  • 8/9/2019 Animal Clinical Chemistry

    22/231

    change in rodents. Similarly, while gamma glutamyl tran

    liver toxicity in the dog, an increase is rarely detected in

    hepatotoxic compound. Other tests suggested by regulatoryassociations have also proved to be controversial.

    Urate (uric acid) measurement is commonly used in hum

    and treatment of gout, rheumatoid arthritis and other con

    metabolism. Urate is the end point of purine metabolism in h

    species are able to further metabolize urate to allantoin res

    values which have little diagnostic value in generadehydrogenase activity is highly variable and lacks specifi

    organ toxicity in animal species (Evans, 1991). The analyt

    performance for plasma ornithine decarboxylase (Carakosta

    i hi b l f (C k l 1986)

    Animal clinical chemistry 14

  • 8/9/2019 Animal Clinical Chemistry

    23/231

    suspected, several urinary enzymes can be measured

    considered (see Chapter 7, Nephrotoxicity).

    The debate about which tests should form the core proclinical toxicity and safety studies has exercised several

    Recent noteworthy recommendations are discussed below. A

    groups have been prominent in publishing recommenda

    testing. In 1992, Stonard published the recommendations

    Toxicology Group which formulated draft OECD Guideline

    chemicals. Subsequently, the IHCPT Committee developefrom an earlier version prepared jointly by the Ameri

    Chemistry and the American Association of Veterinary Clin

    al.,1992). Both documents emphasize that they define mini

    b i d f ll h i b

    Study design and regulatory requirement

  • 8/9/2019 Animal Clinical Chemistry

    24/231

    2.4Good Laboratory Practice (G

    Following the identification of serious flaws in toxicologFood and Drug Administration (FDA) of the United S

    developed a code of practice designed, with periodic

    agencies, to ensure the scientific validity of all studies subm

    Table 2.2Recommendations for c

    chemistry testsOECD Shadow Toxicology Group IHCPT

    Non-fasting glucose Glucose

    Animal clinical chemistry 16

  • 8/9/2019 Animal Clinical Chemistry

    25/231

    Good Laboratory Practice (GLP) Regulation (FDA, 1

    guidelines (OECD, 1982) were subsequently promulgated

    countries.As for all other aspects of non-clinical toxicity and sa

    pathology analyses must be shown to be scientifically

    standards. These GLP regulations cover aspects of personn

    training, general laboratory facilities, calibration and

    performance of reagents and therefore assays, and character

    variables. Great emphasis is placed on adequate documentaraw data and detailed description of any amendments mad

    Appropriate statistical methods should be used to analyse

    and Weil, 1989) and it must be stressed that concurrent con

    h hi i l f f i i h

    Study design and regulatory requirement

  • 8/9/2019 Animal Clinical Chemistry

    26/231

    (GEET-Italy); International Society for Animal Clinical Bio

    Canada, Sweden); Japanese Pharmaceutical Manufacturers

    References

    ALDER, S., JANTON, C. & ZBINDEN, G. (1981) Preclinical safe

    Federal Institute of Technology and University of Zurich.

    CARAKOSTAS, M.C. (1988) What is serum ornithine decarboxyl

    26067.CARAKOSTAS, M.C., GOSSETT, K.A., CHURCH, G.E. & CLE

    Evaluating toxin-induced hepatic injury in rats by laboratory re

    Veterinary Pathology,23,2649.

    Animal clinical chemistry 18

  • 8/9/2019 Animal Clinical Chemistry

    27/231

    3

    Preanalytical and Analytical

    J ROBINSON & G O EVANS

  • 8/9/2019 Animal Clinical Chemistry

    28/231

    Section 3.1Preanalytical Variab

    J.ROBINSON& G.O.EVANSSeveral preanalytical variables must be considered, and th

    influences, gender, age, environmental conditions, chro

    biorhythms), nutrition, fluid balance and stress (Table 3.1.1

    used for sample collection, separation and storage are also im

    3.1.1Species, Strain, Age and Ge

    Animal clinical chemistry 20

  • 8/9/2019 Animal Clinical Chemistry

    29/231

    Fluid balance

    Chronobiochemistry

    Sampling procedures

    Time of sampling

    Sample volume

    Site of sampling

    Agents used for anaesthesia or euthanasia

    Frequency of sampling

    Anticoagulant

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    30/231

    Table 3.1.2Mean percentage cha

    rats fasted overnight compared to controls at 4 and 13 weeks of age

    Robinson, 1975)

    Mean percentage c

    4 weeks

    Parameters Male Fema

    Body mass 11

    Animal clinical chemistry 22

  • 8/9/2019 Animal Clinical Chemistry

    31/231

    intake with consequential perturbations of fluid balance also

    Simple observations of water intake together with urinary

    examining this preanalytical variable.Treatment prior to sequential blood sampling in toxicolo

    in respect to food and water intake. The biochemical

    alterations of nutritionary and fluid balance can be assoc

    absorption or uptake of the test compound, changes in meta

    mechanisms, modification of renal clearance or changes i

    proteins with the test compound. Toxicity may affect both nexaggerate differences between dosed or treatment groups.

    3 1 4 Chronobiochemical Effec

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    32/231

    reported differences in sample quality associated with indi

    shows some of the common sites used for blood collection fr

    Anaesthetics should be chosen on the basis of causing minimal interference effects on the analyte, and minimizing

    Table 3.1.3Species and common

    collection

    Species Sites of collection

    Mouse heart, vena cava, tail vein

    Rat heart, vena cava, aorta, tail vein, retro-orbital plexu

    Animal clinical chemistry 24

  • 8/9/2019 Animal Clinical Chemistry

    33/231

    3.1.6AnticoagulantsLithium heparinate or heparin are suitable anticoagulants fo

    Inappropriate use of anticoagulants, and incorrect proporti

    volumes may also cause errors. Samples collected with se

    citrate used for haematological investigations are not suitab

    enzyme measurements; the inappropriate use of potassium

    low calcium values due to chelation and high potassium check with local laboratories the correct anticoagulant requiWhen collecting blood, it is important to separate the

    possible; this reduces the effects of glycolysis which result i

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    34/231

    3.1.8Urine CollectionsIn general urine collections should be made for fixed t

    overnight) using well-designed metabolism cages. For so

    enzymes the timing of collection period may produce dif

    devices for separating faeces and urines in metabolism ca

    reduction of faecal contamination of the urine. Bacterial

    highly alkaline pH values, may occur if analysis is delayedbiochemical values. Some investigations require the use ofmay be collected over ice. Catheterization and random samp

    in some studies.

    Animal clinical chemistry 26

  • 8/9/2019 Animal Clinical Chemistry

    35/231

    DAVY, C.W., TRENNERY, P.N., EDMUNDS, J.G., ALTMAN, J

    Local myotoxicity of ketamine hydrochloride in the marmoset.

    DROZDOWICZ, C.K., BOWMAN, T.A., WEBB, M.L. & LANGtransport on murine plasma corticosterone concentration and blAmerican Journal of Veterinary Research,51,18416.

    EVANS, G.O. (1985) Lactate dehydrogenase activity in platelets a

    31,1656.(1987) Post-prandial changes in canine plasma creatinine.Journal

    31115.(1994) Removal of blood from laboratory mammals and birds.Lab

    FALK, H.B., SCHROER, R.A., NOVAK, J.J. & HEFT, S.M. (198various serum chemistry parameters from common lab animals

    FOUTS, J.R. (1976) Overview of the field: environmental factors a

    in animals Federation Proceedings 35 11625

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    36/231

    LINDENA, J., BUTTNER, D. & TRAUTSCHOLD, I. (1984) Biol

    experimental components of variance in a long-term study of pl

    of Clinical Chemistry and Clinical Biochemistry, 22,97104.LOEB, W.F. & QUIMBY, F.W. (1989) The Clinical Chemistry of

    Pergamon Press.

    MAEJIMA, K. & NAGASE, S. (1991) Effect of starvation and ref

    of hematological and clinico-biochemical values, and water intaAnimals,40,38993.

    MATSUZAWA, T., NOMURA, M. & UNNO, T. (1993) Clinical plaboratory animals.Journal of Veterinary Medical Science,55,

    MATSUZAWA, T. & SAKAZUME, M. (1994) Effect of fasting ochemistry values in the rat and dog. Comparative Haematology

    MCGOWAN, M.W., ARTISS, J.D. & ZAK, B. (1984) Description

    from elevated serum solids Analytical Biochemistry 142 239

    Animal clinical chemistry 28

  • 8/9/2019 Animal Clinical Chemistry

    37/231

    SCHEVING, L.E., SCHEVING, L.A., FEUERS, R.J., TSAI, T.H.

    Chronobiology as it relates to Toxicology, Pharmacology and C

    Toxicology and Pharmacology,17,20918.SCHWARTZ, E., TORNABEN, J.A. & BOXILL, G.C. (1973) The

    haematology, clinical chemistry and pathology in the albino ratPharmacology,25,51524.

    SONNTAG, O. (1986) Haemolysis as an interference factor in clinClinical Chemistry and Clinical Biochemistry,24,12739.

    STONARD, M.D., SAMUELS, D.M. & LOCK, E.A. (1984) The pinduced by different diets in female rats, and the effect on renal

    Toxicology,22,13946.STREET, A.E., CHESTERMAN, H., SMITH, G.K.A. & QUINTO

    diet on blood urea levels in the beagle.Journal of Pharmacy an

    SUBER R L & KODELL R L (1985) The effect of three phlebot

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    38/231

    Section 3.2Analytical Variabl

    J.ROBINSON& G.O.EVANSIn this section, we discuss some of the analytical variables

    when performing studies and interpreting data. The go

    Association of Societies of Pathology (1979) is that anal

    equal to or less than one-half of the average within subanalytical CV

  • 8/9/2019 Animal Clinical Chemistry

    39/231

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    40/231

    reference materials may be obtained from a commercial so

    an External Quality Assessment Scheme (EQAS).

    Examples of methodological performance are indicated inwhere method A reflects an accurate and precise method, B

    method, C a precise but inaccurate method, and method D

    method.

    Reproducibility, precision or perhaps more correctly

    usually expressed as the degree of agreement between re

    sample, and as a coefficient of variation (CV) where the s

    measure of the dispersion of a group of values around

    percentage of the mean, Values for the CV can be det

    analytical run and between-batch or day.

    l h i hi b h d b b

    Animal clinical chemistry 32

  • 8/9/2019 Animal Clinical Chemistry

    41/231

    Most laboratories participate in an External Quality A

    where samples are distributed on a regular basis to particip

    are compared to overall or group mean values as an indicato

    3.2.2Other Examples of Analytical V

    Sample EvaporationEven with the sophistication of todays analysers, sample

    analytical procedures and this will affect results (Burtis et a1993). This evaporation problem is particularly important in

    samples taken from laboratory animals.

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    42/231

    HormonesSee Chapter 8.

    3.2.3Changing Analytical Meth

    Although assay systems can be modified for use with a

    always easily achieved. The problem for many manufact

    market is too small to justify the expenditure required to

    species-specific. Problems associated with lipid measureme

    analysts to be vigilant when new reagent formulations are inRecognizing the limitations of certain methods in terms

    it must be remembered that the analytical limitations will ap

    Animal clinical chemistry 34

  • 8/9/2019 Animal Clinical Chemistry

    43/231

    Section 3.3Analytical Interfere

    G.O.EVANSWhen examining data from toxicological studies, differen

    clinical chemistry data which cannot be explained simply

    toxicity, histopathological findings, clinical observatio

    preanalytical variables. In these cases it may be wor

    differences are due to the effect(s) of the test compound

    assay(s) in question, and this general consideration of metab

    following section where only the test compound may be men

    Xenobiotics may interfere with analytical methods in sev

    may have a negative or positive effect on the result: these

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    44/231

    species. There is evidence that some of these serum separa

    interact with hydrophobic drugs in human serum (Landt et a

    Some other effects include inappropriate anticoagulantassociated with sequestrenated blood, iron chelators such

    and effects due to intramuscular injections (see Chap

    Myotoxicity).

    3.3.1.2Plasma Protein Binding

    Xenobiotics can bind to the various plasma protein fractionsbinding occurs can have a marked effect on the pharm

    (Goldstein et al.,1974; Lindup and LE Orme, 1981). The

    Animal clinical chemistry 36

  • 8/9/2019 Animal Clinical Chemistry

    45/231

    3.3.3Testing for Analytical Interfe

    Various guidelines have been proposed for testing for

    chemistry measurements and they suggest the necessity fo

    (Powers et al., 1986; Kallner and Tryding, 1989; Kroll an

    several limitations to performing such studies.In vitrostudi

    to clinical practice, e.g. high levels of ascorbic acid interfere

    are rarely seen in vivo. More importantly xenobiotics are o

    range of metabolites, and consideration then has to be gabundance of the metabolite and its availability for testing.

    other drugs can complicate interpretation of effects due to in

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    46/231

    urine must be considered in deciding if the effects are du

    assay, and additional problems occur when more than on

    Following in vivo studies, testing the test compound andtechniques can be useful. Early recognition of potential in

    chemistry measurements during the preclinical or developm

    however, can assist and prevent misleading interpretations

    development results.

    References

    APPEL, W., HUBBUCH, A. & KOLLER, P.U. (1991)In-vitro-Pro

    h k b i i i i l b i i

    Animal clinical chemistry 38

  • 8/9/2019 Animal Clinical Chemistry

    47/231

    KROLL, M.H. & ELIN, R.J. (1994) Interference with clinical laboChemistry,40,19962005.

    KROLL, M.H., NEALON, L., VOGEL, M.A. & ELIN, R.J. (1985negatively with the Jaffe reaction for creatinine. Clinical Chemi

    LANDT, M., SMITH, C.H. & HORTIN, G.L. (1993) Evaluation o

    tubes: effects of three types of polymeric separators on therapeu

    Clinical Chemistry,39,171217.LETELLIER, G. & DESJARLAIS, F. (1985a) Analytical interferen

    chemistry: 1. Study of twenty drugs on seven different instrume34551.

    (1985b) Analytical interference of drugs in clinical chemistry: II. Tcephalosporins with the determination of serum creatinine conc

    Clinical Biochemistry,18,3526.

    LINDUP W E & LE ORME M C L (1981) Plasma protein bind

    Preanalytical and analytical variables

  • 8/9/2019 Animal Clinical Chemistry

    48/231

    4

    Statistical Approach

    A DICKENS & J ROBINSON

    S i i l h 41

  • 8/9/2019 Animal Clinical Chemistry

    49/231

    In the final part of the chapter, different statistical techn

    applied to different types of toxicological data are summariz

    4.2Descriptive Statistics

    4.2.1Diagrams

    It is said that a picture is worth a thousand words. Certai

    which words cannot convey can be very forcefully presente

    the use of statistical diagrams is an important area (particu

    computer packages) and there has been something of a resur

    Statistical approaches 41

    A i l li i l h i t 42

  • 8/9/2019 Animal Clinical Chemistry

    50/231

    Animal clinical chemistry 42

    St ti ti l h 43

  • 8/9/2019 Animal Clinical Chemistry

    51/231

    1 Separate each observation into a stem and a leaf; in generadigits as needed, but each leaf should contain a single dig

    value of 148, the stem would be 14 and the leaf 8.

    Statistical approaches 43

    Animal clinical chemistry 44

  • 8/9/2019 Animal Clinical Chemistry

    52/231

    different from the others on the same treatment, though n

    this should be so. Such an observation

    Animal clinical chemistry 44

    Statistical approaches 45

  • 8/9/2019 Animal Clinical Chemistry

    53/231

    Making a graphical display is the first step towards und

    calculations which give the location of the distribution and

    observations is the second step.

    Figure 4 5 Illustration of ne

    Statistical approaches 45

    Animal clinical chemistry 46

  • 8/9/2019 Animal Clinical Chemistry

    54/231

    Since the number of observations, n=10, is even, the m

    centre observations.

    The median takes no account of the precise magnitude of mtherefore usually less efficient than the mean, because it w

    the mean can be misleading. If we consider the previous ex

    nature of the distribution the mean of 226.2 U/L is not rewhole, and the median of 177.5 U/L might be a more use

    important weakness of the mean as a measure of centre,

    influence of a few extreme values. Similarly, a mean should

    Animal clinical chemistry 46

    Statistical approaches 47

  • 8/9/2019 Animal Clinical Chemistry

    55/231

    The calculation of the quartiles leads to another e

    distribution, the boxplot orbox and whisker plot. In a boxp

    1 The ends of the box are at the quartiles, so that the length orange.

    Statistical approaches 47

    Animal clinical chemistry 48

  • 8/9/2019 Animal Clinical Chemistry

    56/231

    There are several modifications of the above procedure b

    same in all cases, the centre, spread and overall range

    immediately apparent.The most commonly used measure of variability of a

    deviation. This is a measure of spread about the mean, and

    mean is employed as a measure of centre. The varianceof n

    The standard deviation sis the square root of the variance s2

    The idea behind the variance and the standard deviation

    f ll Th d i ti di l th d f th

    Animal clinical chemistry 48

    Statistical approaches 49

  • 8/9/2019 Animal Clinical Chemistry

    57/231

    4.3Some Basic Considerations in Experim

    The design and analysis of experiments is an extensive subjhave been entirely devoted (Davies, 1954; Cochran and C

    design are of course inseparable from those of analysis and

    unless a suitable design is employed, it may be very difficulvalid conclusions from the resulting data.

    Statistical experimental design was founded in the early at an agricultural research station at Rothamsted, Eng

    comparing the yield from several varieties of wheat was pe

    Statistical approaches 49

    Animal clinical chemistry 50

  • 8/9/2019 Animal Clinical Chemistry

    58/231

    4.3.3Blocking

    If the individual units are homogeneous, respond in a c

    treatments, then the experimental error variance will be sma

    will have high precision and it will be relatively easy to d

    individual treatment population means. However, Fisher

    research, the individual plots in a field were anything but

    with respect to fertility, drainage etc. Furthermore, it was

    between units was desirable, in order to give the experimwould produce results applicable to the real world. Thus

    apparently irreconcilable requirementsto design high-p

    Animal clinical chemistry 50

    Statistical approaches 51

  • 8/9/2019 Animal Clinical Chemistry

    59/231

    3 The power (the probability of correctly detecting the differ4 The design itself (how well it controls experimental error)

    5 The number of replicates tested (the number of units per trPrecise details of how to decide upon the appropriate size o

    a variety of books, and the reader is referred to Desu (

    stressing that an over-precise experiment is just as much

    precise one. An experiment which can detect differences b

    means, which are too small to be of any practical (as oppose

    wasteful of valuable resources that could otherwise have beeDetermining sample size is a compromise between

    expected variability of the outcome measure and effect sizeusually known or specified but the latter two are not Whe

    Statistical approaches 51

    Animal clinical chemistry 52

  • 8/9/2019 Animal Clinical Chemistry

    60/231

    this is rather wasteful of data. Methods for ordinal data can

    where one is uncertain of the underlying distribution, for ana

    Although various guidelines (US Food and Drug Admistatistical tests be used to evaluate the data generated from t

    no current standard statistical procedures being used to anal

    (Waner, 1992). There are some published (Gad and

    recommended approaches which summarize the method

    approach for continuous data is shown in Figure 4.7. The m

    be found in most standard statistical texts (Gad and Weil

    1988; Campbell, 1989).The practice of statistics involves many numerical calcul

    some very complex. As you learn how to perform these ca

    l f i i i l l i f i k b i

    Animal clinical chemistry 52

    Statistical approaches 53

  • 8/9/2019 Animal Clinical Chemistry

    61/231

    Suggested Reading

    Basic StatisticsARMITAGE, P. & BERRY, G. (1988) Statistical Methods in Medi

    Blackwell Scientific Publications.

    CLARKE, G.M. & COOKE, D. (1992)Basic Course in Statistics,

    GAD, S. & WEIL, C.S. (1987) Statistics and Experimental Design

    Telford Press.

    Intermediate StatisticsSNEDECOR G W & COCHRAN W G (1980) Statistical Metho

    pp

  • 8/9/2019 Animal Clinical Chemistry

    62/231

    5

    General Enzymolog

    G O EVANS

    General enzymology 55

  • 8/9/2019 Animal Clinical Chemistry

    63/231

    Table 5.1Plasma enzymes and th

    half-lives in three species

    Range of estimates for enz

    Enzyme Dog R

    Aspartate aminotransferase 3.3 to 4.4 2.

    Alanine aminotransferase 2.5 to 60.9 4.

    Creatine kinase 0.6 to 16.2 0.

    Lactate dehydrogenase 1.6

    y gy

    Animal clinical chemistry 56

  • 8/9/2019 Animal Clinical Chemistry

    64/231

    regeneration may also be accompanied by changes in pla

    leakage from the cell, plasma enzyme activities may fall bu

    on the rates of clearance from the circulation. Often theclearances (or half-lives) of plasma enzymes are found

    methodologies used to establish these values. Table 5.1 s

    elimination half-lives for enzymes, and it is particularly

    variables in acute or time-course studies where enzyme chan

    Urinary enzymes may originate from:

    1 proteins of low molecular weight passing into the glomeru2 the renal tubular cells either by desquamation or injury

    3 desquamation or injury of the epithelial cells of the urogen

    4 secretion by the glands of the urogenital tract

    y

    General enzymology 57

  • 8/9/2019 Animal Clinical Chemistry

    65/231

    Table 5.2Enzymes, their abbrevi

    Enzyme Commission (EC) numbe

    Abbreviation Recommended name

    ALT(GPT) alanine aminotransferase

    AAP alanine aminopeptidase

    ALP alkaline phosphatase

    AMY amylase

    AST(GOT) aspartate aminotransferase

    CHE h li t

    Animal clinical chemistry 58

  • 8/9/2019 Animal Clinical Chemistry

    66/231

    5.1.2Aspartate Aminotransferase (

    AST (also known as glutamic oxaloacetate transaminase, GO

    As for ALT, this enzyme is widely distributed in the tissue

    hepatic and renal tissues. It is commonly used in conjunct

    site of tissue damage. Some common texts emphasize its us

    plasma levels of this enzyme do change following th

    hepatotoxins. Mitochondrial and cytosolic forms of AST

    mitochondrial to cytosolic form is generally greater than fo

    General enzymology 59

  • 8/9/2019 Animal Clinical Chemistry

    67/231

    5.1.4Aminopeptidases and Arylami

    These enzyme assays have been linked here as they have s

    diagnostic enzymology.Alanine aminopeptidase (AAP) and leucine arylamidase

    at the N-terminal amino acid and some amino acid amidhydrolyse leucyl- and alanyl-4-nitroanilide substrates. They

    also membrane bound, and they have been used in studie

    nephrotoxicity. These two enzymes should not be conf

    aminopeptidase (LAP): this enzyme is an aminopeptidase

    acid residues of proteins, in particular those with an N-termi

    -napthylamide is commonly used as substrate.

    Animal clinical chemistry 60

  • 8/9/2019 Animal Clinical Chemistry

    68/231

    appear to alter following renal injury but urinary GGT

    monitoring renal tubular damage.In hepatic studies, plasma GGT can be used as an indica

    where plasma GGT levels are normally very low, often less

    as a marker of enzyme induction and of the presence of hep

    in laboratory animals compared with data from human studi

    al.,1992; see Chapter 6).

    5.1.10Lactate Dehydrogenase (LD

    This catalyses the reversible oxidation of lactate to pyruvate

    It is distributed widely in the tissues and the tissue isoenzy

    General enzymology 61

  • 8/9/2019 Animal Clinical Chemistry

    69/231

    5.1.14Other Enzymes

    Arginase, malate dehydrogenase (MDH), isocitrate dehyd

    phosphatase dehydrogenase (G6PDH) and alcohol dehydr

    the many enzymes which have been measured in studies of h

    Glutathione transferases (GST), essential in many detox

    recently not been used widely due to the low levels in plas

    and inhibition by bilirubin and bile acids in the assay. The

    now available have been used in a few laboratories, but nmay widen the use of this enzyme assay.

    Animal clinical chemistry 62

  • 8/9/2019 Animal Clinical Chemistry

    70/231

    absence of data which show that these reagents are totall

    differing species used in toxicology. Variations between spsubstrates have been shown for cholinesterase (Myers, 19

    enzymes, e.g. angiotensin converting enzyme (Evans, 1989

    the majority of methods employ 4-nitrophenylphosphate a

    two main alternative buffersdiethanolamine and 2-amin

    interspecies differences (Masson and Holmgren, 1992).

    For isoenzymes, the majority of laboratories currently us

    separation methods. Selective inhibition of isoenzymes w

    increasingly, but there are problems associated with proisoenzyme concentrations in animal samples.

    Preanalytical factors discussed in an earlier chapter also

    i Si f li i l l f

    General enzymology 63

  • 8/9/2019 Animal Clinical Chemistry

    71/231

    measurements in different species described here, it can be

    one species cannot be used for any other species.In summary, several enzymes should be chosen wi

    specificity for the detection of major organ toxicity. The ch

    reflect their different tissue and intracellular locations. In m

    times should be used with some reference to enzyme produ

    the toxic insult. The use of such approaches is exemplified

    nephrotoxicity, hepatotoxicity and cardiotoxicity. Whethe

    simplicity or suitability for use with automated laborato

    enzymes measured in regulatory studies has not increased dtwo decades.

    Animal clinical chemistry 64

  • 8/9/2019 Animal Clinical Chemistry

    72/231

    DO, T.-X., BOISNARD, P., GIRAULT, A., PLANCHENAULT, P

    (1992) Etude exprimentale des variations diurnes et nocturnes

    enzymatiques rnales de rats Sprague-Dawley. Science et techn

    17,20711.DOOLEY, J.F. (1979) The role of clinical chemistry in chemical a

    of laboratory animals. Clinical Chemistry,25,3457.

    DORNER, J.L., HOFFMAN, W.E. & LONG, G.B. (1974) Corticoisoenzyme of alkaline phosphatase in the dog.American Journa

    14578.ECKERSALL, P.D. (1986) Steroid induced alkaline phosphatase in

    Veterinary Medicine,42,2539.EVANS, G.O. (1985) Lactate dehydrogenase activity in platelets a

    31,165.

    (1989a) More on orthinine decarboxylase Clinical Chemistry 35

    General enzymology 65

  • 8/9/2019 Animal Clinical Chemistry

    73/231

    MASSON, P. & HOLMGREN, J. (1992) Comparative study of alk

    animal samples using methods based on AMP and DEA buffersScandinavian Journal of Clinical and Laboratory Investigation

    MILNE, E.M. & DOXEY, D.L. (1987) Lactate dehydrogenase andand sera of clinically normal dogs.Research in Veterinary Scie

    Moss, D.W. (1982) Alkaline phosphatase isoenzymes. Clinical Ch

    MYERS, D.K. (1953) Studies on cholinesterase: 9. Species variatiothe pseudocholinesterases.Biochemical Journal, 55,6779.

    NAKAMURA, M., ITOH, T., MIYATA, K., HIGASHIYAMA, NNISHIYAMA, S. (1983) Difference in urinary N-acetyl--D-gl

    male and female beagle dogs.Renal Physiology (Basel), 6,130NEPTUN, D.A., SMITH, C.N. & IRONS, R.D. (1985) Effect of sa

    method on variations in baseline pathology parameters in FischFundamental and Applied Toxicology 5 11805

  • 8/9/2019 Animal Clinical Chemistry

    74/231

    6

    Assessment of Hepatoto

    D D WOODMAN

    Assessment of hepatotoxicity 67

  • 8/9/2019 Animal Clinical Chemistry

    75/231

    Liver damage can conveniently be divided into two main

    where direct hepatocyte damage or destruction occurs, awhere the normal flow of bile is reduced without nece

    destruction. Within these two groups, however, many differe

    identified, depending on the specificity of the original dama

    In considering what tests are appropriate for assessing l

    important to appreciate the wide variety of processes with w

    is also vital to remember that functional deficit and damag

    occur quite independently, especially in the early stages of to

    6.2Functions of the Liver

    Animal clinical chemistry 68

  • 8/9/2019 Animal Clinical Chemistry

    76/231

    6.3.1Bilirubin

    Bilirubin is the breakdown product of haem, the porphy

    molecule. It is highly insoluble and toxic and it is partibecause the liver is responsible both for its conjugation with

    more soluble, and for its excretion. It is most common to plasma, but the conjugated and unconjugated forms, for

    indirect bilirubin respectively, can be measured separately

    useful.In man, an increase in plasma bilirubin manifests its

    concentrations above approximately 70 mol/L. Cholestasisignificantly in excess of 340 mol/L. The increase in

    separated plasma becomes obvious at about 30 mol/L i

    Assessment of hepatotoxicity 69

  • 8/9/2019 Animal Clinical Chemistry

    77/231

    6.3.2Bile Acids

    Unlike bilirubin, bile acids are not waste products, but a

    cholesterol and secreted into the intestine to act as lipid emubile acids has historically presented great problems, but the

    and the availability of enzymatic methods have allowed measurement to become a tenable proposition. In most

    practice, plasma bilirubin or alkaline phosphatase has been

    confirming obstructive jaundice. Once clinical jaundicsensitivity of bile acids is of limited use, serving only to con

    In the sphere of toxicology, the sensitivity of bile apositive advantage. Due to difficulties with bilirubin

    measurements in laboratory animals bile acid measuremen

    Animal clinical chemistry 70

  • 8/9/2019 Animal Clinical Chemistry

    78/231

    6.3.3Dye Excretion Tests

    The excretory capacity of the liver can be studied by

    exogenous dyestuffs such as bromosulphthalein (BSP, sulp

    green (ICG) or rose bengal.

    Despite the fact that bromosulphthalein clearance (BSP

    liver function in 1925 (Rosenthal and White, 1925) it rema

    tests available if properly conducted. Other dyes have al

    remains the most widely used. When administered intravento albumin (Baker and Bradley, 1966) and to a lesser exten

    is removed from the circulation almost exclusively by the h

    Assessment of hepatotoxicity 71

  • 8/9/2019 Animal Clinical Chemistry

    79/231

    of enzyme loss from a relatively small number of cells.

    damage, cytoplasmic enzymes may leak from cells whosebeen increased by changes in cellular function. At this sta

    subcellular organelles will be unable to escape and will

    plasma. If the damage process continues and becomes more

    mitochondrial and microsomal enzymes will be released and

    plasma changes will be among the first measurable alteratio

    This phased release can also act as an indicator of the tim

    damage. Plasma half-lives of intracellular enzymes are shor

    days at most, so a rapid rise following damage will quickdamage releases more enzymes. This makes plasma enzym

    useful in acute studies but severely limits their use in ch

    i d d b i i i l d i i h l d d i

    Animal clinical chemistry 72

  • 8/9/2019 Animal Clinical Chemistry

    80/231

    their use has been limited by methodological difficulties, a

    (Carakostas et al.,1986).

    Cholestasis

    Alkaline phosphatase (ALP) has long been the standard en

    despite its shortcomings. While ALP has been applied to mo

    the rat and cat liver, the high intestinal component in rat

    primate plasma activities do not make it an ideal choice

    greatly improve the predictive specificity, but the required e

    as a routine procedure (Kominami et al., 1984). Alternatused, but none has shown wide advantages over ALP. 5N

    used as a more specific liver variant of ALP but wi

    Assessment of hepatotoxicity 73

  • 8/9/2019 Animal Clinical Chemistry

    81/231

    stimulates the liver to synthesize and secrete acute-phase

    damage which is minor or in its early stages may paradoxwhile reducing overall synthetic capacity, initially main

    concentrations.The common pattern seen following significant hepatoc

    in albumin accompanied by a relative increase in ga

    synthesized by the B cells of the lymphoid system), often wi

    total protein. These changes, however, produce an obvious e

    ratio and on the plasma protein electrophoretogram. The

    frequently used in the routine evaluation of liver functionalbumin, the calculation of albumin/globulin ratio and the p

    pattern.

    Animal clinical chemistry 74

  • 8/9/2019 Animal Clinical Chemistry

    82/231

    Greater interest is being shown in drug-metabolizing en

    and decrease. These are not plasma measurements, howeverliver tissue. A variety of demethylating enzymes can be me

    can glucuronidating enzymes such as uridine diphosphate gmixed function oxidase system cytochrome P450 (Hinto

    measurements are not easy because of the use of tissue rat

    direct measurements of liver metabolic capacity and m

    pharmaceutical development.

    6.3.8Drug-induced Hepatotoxic

    The majority of drugs are taken orally and following absorp

    Assessment of hepatotoxicity 75

  • 8/9/2019 Animal Clinical Chemistry

    83/231

    aArithmetic means (and SD) and statistical significances of differen

    test are shown. *p

  • 8/9/2019 Animal Clinical Chemistry

    84/231

    is dose dependent and rapid (Breen et al.,1975). Despite thi

    levels is generally less than that seen with drugs inducing ne

    6.3.10Cholestasis

    A second major area of drug-induced toxicity is cholestasis.

    shown capable of causing cholestasis but in animals

    unpredictable. Oral administration of naphthylisothiocyan

    produces a highly predictable and dose-dependent cholesta

    Cholestasis occurs 1524 h after a single dose of ANIT i(Capizzo and Roberts, 1971) and damage to the cells lining

    by electron microscopy 3 h after dosing (Schaffner et al

    Assessment of hepatotoxicity 77

  • 8/9/2019 Animal Clinical Chemistry

    85/231

    Table 6.2aEnzyme activities in r

    ANIT administrationa

    AP ALT GD

    Treatment group Activities, IU/L a

    Control 587.3(86.8) 31.0(3.2)

    ANIT, 30 mg/kg 576.2(106.0) 35.1(3.2)***

    ANIT, 60 mg/kg 986.6(249.6)*** 234.5(129.9)*** 24

    ANIT, 120 mg/kg 1285.8(193.8)*** 439.9(129.3)*** 39

    Animal clinical chemistry 78

  • 8/9/2019 Animal Clinical Chemistry

    86/231

    pyridoxal phosphate results in no loss in enzyme activity. Th

    seen originally does not reflect any damage to the liver osynthesize the enzyme, but an action directly on the enzym

    interferes with the binding of pyridoxal phosphate, aminotransferases, to the enzyme protein. Stripped of its co

    has no catalytic activity and is not measured by normal e

    treatment with excess pyridoxal phosphate restores the activ

    Assessment of hepatotoxicity 79

  • 8/9/2019 Animal Clinical Chemistry

    87/231

    can provide a highly sensitive means of detecting even min

    analytical techniques and the introduction of new indices wmay modify this choice from time to time. Examples of su

    the thymol turbidity test and the resurgence of interest introduction of RIA and enzyme assays.

    The importance of accurately assessing liver damage

    constant re-examination and improvement of the laborator

    needs to be done in particular on the peripheral metaboli

    enzymes and on the metabolism and excretion of specific b

    These areas offer some of the most promising possibilitiesof currently available tests and further clarifying the l

    damage.

    Animal clinical chemistry 80

  • 8/9/2019 Animal Clinical Chemistry

    88/231

    DAVISON, S.C. & WILLS, D. (1974) Studies on the lipid compos

    reticulum after induction with phenobarbitone and 20-methylchJournal,140,4618.

    DE SCHEPPER, J. & VAN DER STOCK, J. (1971) Influence of sexcretion at increased free plasma haemoglobin levels in whole

    normothermic perfused dog kidneys.Experientia,27,12645.

    (1972) Increased urinary bilirubin excretion after elevated free plasVariations in the calculated renal clearance of bilirubin in whol

    de Physiologie et de Biochimie,80,27991.DHAMI, M.S.I., DRANGOVA, R., FARKAS, R., BALAZS, T. &

    aminotransferase activity of serum and various tissues in the ratClinical Chemistry, 25,12636.

    DOOLEY, J.F., TURNQUIST, L.J. & RACICH, L. (1979) Kinetic

    dehydrogenase activity with a centrifugal analyser Clinical Ch

    Assessment of hepatotoxicity 81

  • 8/9/2019 Animal Clinical Chemistry

    89/231

    KORSRUD, G.O., GRICE, H.C. & MCLAUGHLAN, J.M. (1972)

    enzymes in detecting carbon-tetrachloride-induced liver damagePharmacology,22,47483.

    LEONARD, T.B., NEPTUN, D.A. & POPP, J.A. (1984) Serum gaspecific indicator of bile duct lesions in the rat liver.American J

    9.

    LEWIS, J.H. (1984) Hepatic toxicity of nonsteroidal anti-inflamma3,12838.

    LOMBARDI, B. (1966) Considerations on the pathogenesis of fattInvestigation,15,120.

    MARTIN, J.F., MIKULECKY, M., BLASCHKE, T.F., WAGGONBERK, P.D. (1975) Differences between the indocyanine green

    men and women. Proceedings of the Society for Experimental B

    17

    Animal clinical chemistry 82

  • 8/9/2019 Animal Clinical Chemistry

    90/231

    TUCKER, R.A. (1982) Drugs and liver disease: a tabular compilat

    histopathological changes that can occur in the liver.Drug Intel

    16,56980.

    WHITBY, L.G., PERCY-ROBB, I.W. & SMITH, A.F. (1984)LecChemistry. Liver Disease,pp. 16991. Oxford: Blackwell.

    WOODMAN, D.D. (1981) Plasma enzymes in drug toxicity. In Go

    Toxicity Testing Methods,pp. 14556. London: Taylor & Franc(1988) Assessment of hepatic function and damage in animal speci

    Toxicology,8,24954.WOODMAN, D.D. & MAILE, P.A. (1981) Bile acids as an index

    Chemistry,27,8468.ZIMMERMAN, H. (1974) Hepatic injury caused by therapeutic ag

    Liver,pp. 225302. New York: Marcel Dekker.

    (1978) Hepatotoxicity: The Adverse Effects of Drugs and Other Ch

  • 8/9/2019 Animal Clinical Chemistry

    91/231

    7

    Assessment of Nephroto

    M D STONARD

    Animal clinical chemistry 84

  • 8/9/2019 Animal Clinical Chemistry

    92/231

    7.2Laboratory Investigations

    Several of the current screening methods for nephrotoxicity

    those used in clinical practice. However, it cannot be assumenzyme which has found extensive application in human cli

    have the same diagnostic effectiveness in animal species. N

    of certain blood plasma and urinary analytes in combinatio

    nephrotoxicity (Berndt, 1976; Diezi and Biollaz, 1979; Pipe

    et al.,1988; Stonard, 1990).

    When the kidneys are unable to excrete some normal brate, the retention of these materials leads to an increase in t

    creatinine and urea. However, urine rather than blood, is th

    Assessment of hepatotoxicity 85

  • 8/9/2019 Animal Clinical Chemistry

    93/231

    detected conveniently by test strips using glucose oxidase

    be affected by several interferents, including ascorbate. enhanced excretion because of elevated blood levels or be d

    tubules, where glucose is reabsorbed.Changes of hydrogen ion concentration (pH) may reflec

    or they may simply reflect dietary protein composition. The

    cationic and anionic composition and will be influenced by

    the excretion of individual ions, including hydrogen ion

    metabolism produce an excess of acid substances, which a

    system in the kidney. Urine samples from dog and man

    ammonium ions, due to processes of ionic changes that oc

    nephron and also reflecting the nature and composition of t

    i

    Animal clinical chemistry 86

  • 8/9/2019 Animal Clinical Chemistry

    94/231

    Casts may form in the tubular lumen, and appear to cons

    can trap exfoliated cells and debris. Casts may be hyamucoprotein is known to be the Tamm-Horsfall protein, w

    region of the nephron and is thought to be involved in selectCrystals may also be detected microscopically in urine s

    largely pH-dependent, e.g. phosphates or urates, and

    corresponds to regions of the nephron where the tubular

    changes in concentration. Crystals may also reflect

    administered substance or metabolite whose solubility char

    exceeded.

    Reduced fluid intake or excessive fluid loss by vomitus

    output. Although measurements of urine cations, e.g. sodiu

    id f h id f l d f i hi i

    Assessment of hepatotoxicity 87

  • 8/9/2019 Animal Clinical Chemistry

    95/231

    et al., 1981; Viau et al.,1986). However, the selection of

    availability of suitably purified proteins and specific antiseraPrimary tubular disorders may be distinguished from glo

    of high- and low-molecular-weight proteins in the urineelectrophoretic support media and buffers can provide a

    composition of urinary proteins (Boesken et al.,1973; Allch

    et al.,1987).

    7.4Functional Assessment

    The kidneys possess the capacity to filter out, via the g

    Animal clinical chemistry 88

  • 8/9/2019 Animal Clinical Chemistry

    96/231

    plasma or serum urea). Glomerular function, plasma cre

    extent, all show variation with age (Corman et al.,1985; GoThe anionic compound,p-aminohippuric acid (PAH) ca

    renal plasma flow, since it is filtered by the glomeruli and (Tune et al.,1969). PAH clearance can be used to estimat

    the combined processes of glomerular filtration and tub

    entering the kidney by the arterial supply almost completely

    In the dog, approximately 8090% of PAH in arterial bloo

    the venous blood supply leaving the kidneys. The proxim

    primary site for the secretion of PAH. However, PAH clear

    accurate estimate of renal plasma flow, as part of the rena

    non-glomerular pathways.

    A d i f A l b d l i

    Assessment of hepatotoxicity 89

  • 8/9/2019 Animal Clinical Chemistry

    97/231

    Table 7.1Localization of renal tu

    the rat

    Enyzme EC No. Localization

    Alanine aminopeptidase

    (AAP)

    EC 3.4.11.1

    (cytosol)

    EC 3.4.11.2

    (microsomes)

    PST>PCT

    Alkaline phosphatase (ALP) EC 3.1.3.1 PCT>PST>distal tub

    Animal clinical chemistry 90

  • 8/9/2019 Animal Clinical Chemistry

    98/231

    dilution prior to analysis will suffice. This pretreatmen

    essential for most urinary enzymes if erroneous results arremove interfering endogenous substances should be estab

    The majority of enzymes show some instability in a hostilshould be assayed as rapidly as possible after any pretreatm

    involved in the elimination of drugs, it may be necess

    incubation of the enzyme with the drug at concentrations ex

    order to demonstrate any potential interference. However

    possibility that enzyme activity may be affected by wate

    identity may not have been established.

    Several experimental studies have established the role of

    early markers of renal injury (Hofmeister et al.,1986) but a

    h h l di i h h i

    Assessment of hepatotoxicity 91

  • 8/9/2019 Animal Clinical Chemistry

    99/231

    measurements can be more informative than that of total en

    1984).

    References

    ALDEN, C.L. (1986) A review of unique male rat hydrocarbon nepPathology,14,10911.

    ALLCHIN, J.P. & EVANS, G.O. (1986a) A simple rapid method f

    proteins by agarose electrophoresis and nigrosine staining.Labo

    (1986b) A comparison of three methods for determining the concenComparative Biochemistry Physiology,85A,7713.

    ALLCHIN, J.P., EVANS, G.O. & PARSONS, C.E. (1987) Pitfalls

    Animal clinical chemistry 92

  • 8/9/2019 Animal Clinical Chemistry

    100/231

    DIEZI, J. & BIOLLAZ, J. (1979) Renal function tests in experimenPharmacology and Therapeutics,5,13545.

    ELLIS, B.G. & PRICE, R.G. (1975) Urinary enzyme excretion dur

    induced in rats with ethyleneimine. Chemical Biological InteraELLIS, B.G., PRICE, R.G. & TOPHAM, J.C. (1973) The effect of

    chloride on kidney function and some urinary enzymes in the do

    Interactions,7,10113.EVANS, G.O. (1986) The use of an enzymatic kit to measure plasm

    three other species. Comparative Biochemistry and Physiology,

    (1987) Post-prandial changes in canine plasma creatinine.Journal

    31115.

    EVANS, G.O. & PARSONS, C.E. (1986) Potential errors in the mmale rat urine using test strips.Laboratory Animals,20,2731.

    FENT K MAYER E & ZBINDEN G (1988) Nephrotoxicity sc

    Assessment of hepatotoxicity 93

  • 8/9/2019 Animal Clinical Chemistry

    101/231

    renal protein fraction containing alpha 2globulin. Toxicology

    18292.

    LOVETT, D.H., RYAN, J.L., KASHGARIAN, M. & STERZEL, R

    in glomerular cells of the rat.American Journal of Pathology,1MAGIL, A.B., MAVICHAK, V., WONG, N.L.M. et al.(1986) Lo

    biochemical observations in Cisplatin induced hypomagnesaem

    MATTENHEIMER, H. (1977) Enzymes in renal diseases.Annals 7,42232.

    NEUHAUS, O.W. & FLORY, W. (1978) Age-dependent changes proteins by the rat.Nephron,22,5706.

    PARIAT, C.L.,INGRAND, P., CAMBAR, J., DE LEMOS, E., PIR

    (1990) Seasonal effects on the daily variations of gentamicin-inof Toxicology,64,2059.

    PESCE A J (1974) Methods used for the analysis of proteins in th

    Animal clinical chemistry 94

  • 8/9/2019 Animal Clinical Chemistry

    102/231

    STROO, W.E. & HOOK, J.B. (1977) Enzymes of renal origin in u

    nephrotoxicity. Toxicology and Applied Pharmacology,39,423

    TUNE, B.M., BURG, M.B. & PATLAK, C.S. (1969) Characteristi

    renal tubules.American Journal of Physiology,

    217,

    105763.VIAU, C., BERNARD, A. & LAUWERYS, R. (1986) Determinati

    urine and in serum, 1. Development of an immunoassay based o

    Journal of Applied Toxicology, 6,1859.WERNER, M. & GABRIELSON, D. (1977) Ultrafiltration for imp

    Clinical Chemistry,23,7004.WERNER, M., MARUHN, D. & ATOBA, M. (1969) Use of gel fi

    enzymes.Journal of Chromatography,40,25463.

    Woo, J., FLOYD, M., CANNON, D.C. & KAHAN, B. (1978) Radalbumin. Clinical Chemistry,24,14647.

    WRIGHT P J LEATHWOOD P D & PLUMMER D T (1972)

  • 8/9/2019 Animal Clinical Chemistry

    103/231

    8Assessment of Endocrine T

    Animal clinical chemistry 96

  • 8/9/2019 Animal Clinical Chemistry

    104/231

    3 interference with the release mechanism for the hormone4 alteration of capacity of carrier proteins

    5 alteration of hormone catabolism, e.g. via hepatic or renal

    6 interaction with a secondary messenger system, e.g. cyclic

    and several of these are exemplified by cases of thyroid toxi

    Various methods can be used to detect toxic effects on

    include:

    1 measurement of endocrine organ mass (absolute and relati

    2 histological examination of endocrine organ3 measurement of circulating hormones

    4 immunocytochemical examination of endocrine organ

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    105/231

    Table 8.1.1Trophic and releasing

    their abbreviations

    Hormone (abbreviation)

    Adenohypophysis:

    Adrenocorticotrophic hormone (ACTH)

    Thyrotrophin or thyroid stimulating hormone (TSH)

    Follitrophin or follicle stimulating hormone (FSH)Luteotrophin or luteinizing hormone (LH)

  • 8/9/2019 Animal Clinical Chemistry

    106/231

  • 8/9/2019 Animal Clinical Chemistry

    107/231

    Animal clinical chemistry 100

  • 8/9/2019 Animal Clinical Chemistry

    108/231

    The effects of stress and wide intra-animal variations ofte

    of hormone assays in laboratory animals. Effects of procedures on prolactin, thyrotrophin, follitrophin, luteotr

    T4 measurements have been described in rats (Wuttke an1972; Dohler et al.,1977; Gartner et al.,1980), rabbits (T

    (Garnier et al.,1990), and monkeys (Torii et al.,1993). E

    including corticosterone are given in Sections 8.2 and 8.3.

    Some hormones show cyclical rhythms and the timing o

    factor (Kreiger, 1979). Apart from the obvious changes in

    particularly in females, periodic variations of other hormo

    Circadian variations for TSH, T3 and T4 have been describeand for testosterone in dogs (Fukuda, 1990). LH, FSH, pr

    b h f ll l h h i l h k

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    109/231

    MISTRY, A. & VOOGT, J.L. (1989) Role of serotonin in nocturna

    in the pregnant rat.Endocrinology,125,287580.

    RIBELIN, W.E. (1984) Effects of drugs and chemicals upon the strFundamental and Applied Toxicology,4,10519.

    SARGENT, R.N. (1985) Determination of corticosterone in rat plaAnalytical Toxicology, 9,201.

    TORII, R., KITAGAWA, N., NIGI, H. & OHSAWA, N. (1993) Efat 30-minute intervals during 24-hour serum testosterone, LH an

    Japanese monkeys, (Macaca fuscata). Experimental Animals,4

    TOTH, L.A. & JANUARY, B. (1990) Physiological stabilisation o

    Laboratory Animal Science,40,3847.

    WOODMAN, D.D. (1988) The use of clinical biochemistry for asstoxicology. In Keller, P. and Bogin, E. (eds), The Use of Clinica

    Toxicologically Relevant Animal Models and Standardisation a

    Animal clinical chemistry 102

  • 8/9/2019 Animal Clinical Chemistry

    110/231

    adenosine triphosphate. Thyroid hormones are also known

    and messenger RNA (mRNA) synthesis while stimulatingATPase) of the cell membrane.

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    111/231

    normal cuboidal epithelial cells linked at their apical (inner

    These cells show microvilli and pseudopodia at the surfaccolloid while their basal surfaces are closely apposed

    morphology of the follicles vary according to the functiunstimulated glands show a flattened epithelium and dense

    shows tall, columnar epithelium often with the follicular cel

    together with a watery colloid in the follicular lumen. The

    the highly stimulated gland consists largely of highly active

    forming small follicles with small colloid spaces. Interspers

    thyroid C (parafollicular) cells. A more detailed description

    in Greaves (1990).

    Animal clinical chemistry 104

  • 8/9/2019 Animal Clinical Chemistry

    112/231

    released into the circulation is T4, which is usually consider

    Tri-iodotyrosine (T3) is about fourfold more potent than thythe T4secreted undergoes 5-deiodination to the active T3in

    ring deiodination of T4 can also occur with the formationreverse T3(rT3).

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    113/231

    0.04% of total unbound). It is the unbound form of each ho

    active.The thyroid stimulating hormone (TSH), released from t

    most aspects of thyroxine synthesis and secretion. TSiodination of thyroglobulin, endocytosis of thyroglobulin a

    colloid with release of thyroid hormones. The rate of release

    finely controlled by the amount of thyrotropin releasing ho

    hypothalamus and by the circulating levels of T4 and T3.

    there is a decrease in the circulating levels of thyroid hor

    thyroid function is increased; if, on the other hand, circul

    increase, TRH secretion is suppressed and eventually the thand regresses. This dynamic feedback mechanism func

    i d bl i l i l l f h id h

    Animal clinical chemistry 106

  • 8/9/2019 Animal Clinical Chemistry

    114/231

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    115/231

    8.2.5.1Interference with Iodide Tra

    The iodide-concentrating mechanism, which resides wit

    membrane, can concentrate iodide to levels approximately

    plasma. Thyroid stimulating hormone enhances the trainorganic ions such as thiocyanate, perchlorate, dithiocarbadichlorodiphenyl trichloroethane (DDT) inhibit iodide trap

    Netter, 1974; Kuzan and Prahlad, 1975; Bowman and Rand,

    8.2.5.2Interference with Iodide Oxi

    The oxidation of the iodide (I) to iodine (I2) catalysed

    inhibited by thyrotoxic agents such as thiouracil thiourea

    b h b bi d i ifi i i li

    Animal clinical chemistry 108

  • 8/9/2019 Animal Clinical Chemistry

    116/231

    by phenobarbitone, produces a significant increase in liv

    proliferation of hepatic endoplasmic reticulum. Induction ishepatic cytochrome P450 and a large number of oxida

    oxygenases. The chlorinated hydrocarbon insecticides (Dexhibit induction characteristics similar to phenobar-bitone.

    The effect of phenobarbitone-like inducers on thyroid

    complex. Animals treated with phenobarbitone show increa

    T4combined with enhanced biliary excretion of the hormon

    1971). In rats, these changes result from an increased ra

    compensated by the release of TSH and enhanced secretion

    The second class of inducers, typified by the polycycholanthrene (3MC), do not cause an increase in liver size

    h h 448 ( l 19 8) d f h 3

    b d lb i Thi h l ffi i f h i d

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    117/231

    bound to albumin. This has a low affinity for thyroxine and,

    T4in the rat is about 12 to 16 hours. In addition, the ratio orate of the liver in the rat is 2.5 times higher than in man (L

    observations indicate a much higher turnover of the thyroserum TSH is 25 or more times higher in the rat compa

    1979). This indicates a much higher activity in the rat t

    primates, a conclusion supported by the histomorphology o

    often appears to be hypertrophic and hyperplastic, even in h

    This is supported by the observation that rats require a

    rate per kilogram body weight than do humans to maintain

    (Dohler et al., 1979). Several compounds have an indirecbinding. These compounds include phenytoin which reduces

    l i i b h d d li l hi h

    Animal clinical chemistry 110

  • 8/9/2019 Animal Clinical Chemistry

    118/231

  • 8/9/2019 Animal Clinical Chemistry

    119/231

    1 Th d h it i ti it i i (i th id

    Animal clinical chemistry 112

  • 8/9/2019 Animal Clinical Chemistry

    120/231

    1 The compound has goitrogenic activity in vivo(i.e. thyroidhyperplasia).

    2 There are clinical chemistry indications of changes in thyr

    (i.e. reduced thyroid hormone and increased TSH plasma3 There is specific evidence that the agent either reduces thy

    inhibits iodine uptake) or increases thyroid hormone clearexcretion).

    4 A progression of lesions in studies of various duration, sho

    and hyperplasia, nodular hyperplasia, and neoplasia (ben

    tumours) can be demonstrated.

    As for other carcinogens, it is important to quantify the rthreshold dose levels for the various toxicological end

    ith a greater than 80% red ction in rat plasma th ro ine

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    121/231

    with a greater-than-80% reduction in rat plasma thyroxine

    TSH being observed after five daily doses of PTU (Daviehave been noted in response to direct-acting goitrogens

    particularly susceptible to these compounds. Following ethylene thiourea to rats and mice, thyroxine but not T3w

    90-day duration of the study. Plasma TSH values, in contra

    at 7, 28 and 90 days in the mouse but, in the rat, following

    to control values by day 90, despite the continued suppress

    (Elcombe, personal communication). However, in the beagl

    PTU at the compounds maximally tolerated oral dose fo

    plasma T3and T4values until at least day 14. A slight increaapparent after a further 3 days and the maximum va

    i l d bl h b d d

    1 U t l t 20 t

    Animal clinical chemistry 114

  • 8/9/2019 Animal Clinical Chemistry

    122/231

    1 Use at least 20 rats per sex per group.2 Collect blood samples at necropsy rather than multiple inte

    3 Confine the time for collecting the blood to a 1-hour perio

    associated with circadian rhythms.4 Samples should be collected at regular intervals after the s

    observe plasma/serum changes prior to onset of homeost5 Store the samples at 20 or 70C and analyse all samples

    the end of the study.

    8.2.8.2Plasma Hormone Clearance Compound-induced changes in hepatic microsomal enzym

    8 2 9 Conclusions

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    123/231

    8.2.9Conclusions

    There is now a wealth of literature devoted to understand

    thyroid-pituitary axis and to describe in detail how the func

    be disrupted by various xenobiotics. The rat thyroid glansensitive to adverse effects on these compounds andoncogenicity studies, results in the development of thyroid f

    time, ionizing radiation is the only acknowledged human t

    well established in experimental systems also. Although hustimuli as do animals, with the development of cellular h

    sometimes nodular lesions, even in its moderate to severe

    aetiological factor for human thyroid cancer.

    Because of marked species differences in thyroid gla

    BOWMAN W C & RAND M J (1980) Textbook of Pharmacolo

    Animal clinical chemistry 116

  • 8/9/2019 Animal Clinical Chemistry

    124/231

    BOWMAN, W.C. & RAND, M.J. (1980) Textbook of Pharmacolo

    BROWN, C.G. (1987) Application of thyroid cell culture to the stu

    C.K. and Steele, C.E. (eds),In Vitro Methods in Toxicology,p.

    University Press.

    BROWN, C.G., HARLAND, R.F., MAJOR, I.R. & ATTERWILLdoses of novel histamine (H2) antagonist on the rat thyroid glan

    Toxicology,25,78794.CAPEN, C.C. (1983) Chemical injury of thyroid: pathologic and m

    Toxicology Forum:1983 Annual Winter Meeting, pp. 26073. Company.

    CAPEN, C. & MARTIN, S. (1989) The effects of xenobiotics on th

    thyroid follicular and C cells. Toxicologic Pathology,17,2669CAVALIERI, R.R. & PITT-RIVERS, R. (1981) The effects of dru

    metabolism of thyroid hormones Pharmacological Review 33

    HILL R N ERDREICH L S PAYNTER O E ROBERTS P A

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    125/231

    HILL, R.N., ERDREICH, L.S., PAYNTER, O.E., ROBERTS, P.A

    WILKINSON, C.F. (1989) Thyroid follicular cell carcinogenesToxicology,12,62997.

    HUFF, J.E., EUSTIS, S.L. & HASEMAN, J.K. (1989) Occurrence

    induced benign neoplasms in long-term carcinogenicity studies122.

    KANEKO, J.J. (1980) Thyroid function. In Kaneko, J.J. (ed.), ClinAnimals,3rd Edn, pp. 491512. New York: Academic Press.

    KUZAN, F.B. & PRAHLAD, K.V. (1975) The effect of 1, 2, 3, 4, 8a-hexahydroxyendo,exo-5,8-dimethionaphthalene (aldrin) and

    carbomate (Nabam) on the chick. Poultry Science,54,105464

    LATROPOULOS, M.J. (1993/94) Endocrine considerations in toxiToxicologic Pathology,45,391410.

    LUEPRASITSAKUL W FANG S L ALEX S & BRAVERMA

    PENDERGRAST W J MILMORE B K & MACUS S C (1961

    Animal clinical chemistry 118

  • 8/9/2019 Animal Clinical Chemistry

    126/231

    PENDERGRAST, W.J., MILMORE, B.K. & MACUS, S.C. (1961

    thyrotoxicosis in the United States. Their relationship with endeDisease,13,2238.

    POTTER, C.L., SIPES, I.G. & RUSSEL, D.H. (1983) Hypothyrox

    in responses to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin administrPharmacology,69,8995.

    READER, S.J. (1987) Assessment of the biopotency of antithyroidcells.Biochemistry and Pharmacology,36,18258.

    REFETOFF, S., ROBIN, N.I. & FANG, U.S. (1970) Parameters ofselected vertebrate species: a study of PBI, serum T4, free T4an

    binding to serum protein.Endocrinology,86,793805.

    RON, E., KLEINERMAN, R.A., BOICE, J.D., LIVOLSI, V.A., FLJ.F. (1987) A population-based case-control study of thyroid caCancer Institute 79 112

    (1982c) Desensitisation of rat thyroid to the growth-stimulating act

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    127/231

    (1982c) Desensitisation of rat thyroid to the growth stimulating act

    goitrogen administration.Acta Endocrinology,101,5629.

    Section 8.3Other Endocrine Org

    G.O.EVANSTests for assessing the functionality and injury to several o

    than the thyroid glands will be discussed in this section. It

    general frequency of toxic findings in these organs (see Sec

    role of reproductive and teratological studies in the dreproductive systems.

    Animal clinical chemistry 120

  • 8/9/2019 Animal Clinical Chemistry

    128/231

    important for the biological activity in the target tissues.

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    129/231

    important for the biological activity in the target tissues.

    plasma proteins including transcortin (or cortico-steroid albumin; these proteins have differing affinities and binding

    Transcortin is synthesized in the liver and it appears to be

    and Doe, 1966; Westphal, 1971), but its functions are not w

    of hepatic toxicity or excessive renal loss of protein, some

    caused by changes in plasma binding proteins.

    The mineralocorticoids influence electrolyte transport by

    and excretion of sodium, chloride, hydrogen and potassium

    pressure homeostasis. The primary mineralocorticoid is al

    dependent upon the renin-angiotensin system, plasmaconcentrations. Major changes due to adrenal toxicity, th

    h i l l b l i h i h

    A circadian rhythm has been demonstrated for plasma a

    Animal clinical chemistry 122

  • 8/9/2019 Animal Clinical Chemistry

    130/231

    A circadian rhythm has been demonstrated for plasma a

    Sanchez et al., 1976) and in the rabbit (Vernay et al., 19influence levels of plasma aldosterone (Kotchen et al.,

    measurements are of little value as less than 1% of secr

    unchanged via the kidneys.

    Problems in collecting suitable basal blood samples from

    using in-dwelling catheters, as other blood-sampling method

    epinephrine, norepinephrine and catecholamines (Kvetnans

    1978).

    8.3.2Gonads

    Table 8 3 1 Major functions of pi

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    131/231

    Table 8.3.1Major functions of pi

    Hormone Function

    Adenohypophysis

    ACTH Stimulates production of glucocorticosteroids by adren

    FSH Stimulates ovarian follicle growth and spermatogenesi

    GH Accelerates tissue growth.

    LH Induces follicular maturation, ovulation, formation of c

    secretion.Stimulates androgen secretion in males.

    Animal clinical chemistry 124

  • 8/9/2019 Animal Clinical Chemistry

    132/231

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    133/231

    such as alteration of ovarian microsomal mono-oxygena

    Animal clinical chemistry 126

  • 8/9/2019 Animal Clinical Chemistry

    134/231

    yg

    Wilson and Leigh, 1992; Ratcliffe et al.,1993). Chemicalspituitary-ovarian axis can inhibit release of gonadotrophin

    effect on ovarian steroid synthesis. Changes in oestrogenic

    alterations of immune functions (Luster et al.,1985).

    Ovulatory cycles are highly variable in the different spec

    patterns of the plasma reproductive hormones together with

    cause problems when interpreting results from these assay

    8.1). Further complications include reproductive senescence

    rats develop irregularities in their oestrous cycle at about ten

    changes in plasma hormone levels induced by test compounAlthough some studies have shown correlation between

    l i l l i d h l b i di

    measure inactive fragments of PTH in addition to the in

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    135/231

    measure the amino- or N-terminal region of the polypeptidassays for the carboxy- or C-peptide fragment, which is bi

    calcitonin are both measurable by radioimmunoassay (Selb

    PTH values vary with age (Kalu et al.,1983; Kalu and H

    status (Talmage et al,1975)

    Parathyroid toxicity can sometimes be detected by measu

    usually measured as total calcium. As approximately 30 t

    bound to albumin with some binding to the globulin fract

    total calcium levels should always allow for variatio

    measurements of ionized or unbound plasma calcium fractioToxic injury to the parathyroids following acute o

    bi i l b h id f i b

    (1989) The calcium regulating hormones parathyroid hormone, cal

    Animal clinical chemistry 128

  • 8/9/2019 Animal Clinical Chemistry

    136/231

    McDonald, L.E. (ed.), Veterinary Endocrinology,4th Edn, pp. 9

    Febiger.

    CAPEN, C.C. & MARTIN, S.L. (1989) Mechanisms that lead to d

    animals. Toxicologic Pathology,17,23449.CAPEN, C.C. & ROSOL, T.J. (1989) Recent advances in the struc

    parathyroid gland in animals and the effect of xenobiotics. Toxi

    CHENG, C.Y., MUSTO, N.A., GUNSALUS, G.L., FRICK, J. & B

    two forms of androgen binding proteins in human testes.Journa

    563140.

    COLBY, H.D. (1987a) The adrenal cortex. In Hedge, G.A., Colby,

    Clinical Endocrine Physiology,pp. 12759. Philadelphia: W.B(1987b) The adrenal medulla. In Hedge, G.A., Colby, H.D. & GooEndocrine Physiology pp 297315 Philadelphia: W B Saunde

    HAQQI, T.M. & ADHAMI, U.M. (1982) Testicular damage and c

    i d d b l i l b l h l d f h l i lb

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    137/231

    patterns induced by multiple sub-lethal doses of apholate in alb

    199205.

    HILFENHAUS, M. (1977) Urinary excretion of corticosterone as a

    function in rats.Naunuyn Schmiedebergs Archives of PharmacoITOH, R. & OZASA, H.K. (1985) Changes in serum lactate dehyd

    observed after cadmium administration. Toxicology Letters,28,

    JOHNSON, A.N. (1989) Comparative aspects of contraceptive ster

    dogs. Toxicologic Pathology,17,38995.JOHNSTON, S.D. & MATHER, E.C. (1978) Canine plasma cortis

    by radioimmunoassay: clinical absence of diurnal variation and

    and dexamethasone suppression tests.American Journal of VetJONES, M.K., WEISENBURGER, W.P., SIPES, I.G., RUSSELL,

    alterations in prolactin corticosterone and thyroid hormone lev

    MOORE, N.P., CREASY, D.M., GRAY, T.J.B. & TIMBRELL, J.

    fil f d i i i f ll ifi i h

    Animal clinical chemistry 130

  • 8/9/2019 Animal Clinical Chemistry

    138/231

    profiles after administration of cell-specific toxicants to the rat.

    43542.

    ORTH, D.N., PETERSON, M.E. & DRUCKER, W.D. (1988) Plas

    propiomelanocortin peptides and cortisol in normal dogs and dodiurnal rhythm and response to various stimuli.Endocrinology,

    PLANT, T.M. (1981) Time courses of concentrations of circulatingtestosterone and cortisol in adult male rhesus monkeys (Macaca

    light-dark cycle.Biology and Reproduction, 25,24452.POPPER, C.W., CHIEUH, C.C. & KOPIN, J.J. (1978) Plasma cate

    unanaesthetized rats during sleep, wakefulness, immobilization

    of Pharmacology and Experimental Therapeutics, 202,1448.RATCLIFFE, J.M., MCELHATTON, P.R. & SULLIVAN, F.M. (

    Ballantyne B Marrs T & Turner P (eds) General and Appli

    TIMBRELL, J.A., DRAPER, R. & WATERFIELD, C.J. (1994) Bi

    f ld l l T i l d E i l N

    Assessment of endocrine toxicity

  • 8/9/2019 Animal Clinical Chemistry

    139/231

    uses for some old molecules. Toxicology and Ecotoxicology Ne

    VERNAY, M., MARTY, J. & MOALTI, J. (1984) Absorption of e

    in the hind-gut of the rabbit. Circadian rhythm of hind-gut elect

    British Journal of Nutrition, 52,41928.WESTPHAL, U. (1971) Steroid Protein Interactions,pp. 164350

    WHEAT, T.E., HINTZ, M., GOLDBERG, E. & MARGOLIASH, specific multiple forms of lactate dehydrogenase and of cytochr

    the mouse.Differentiation, 9,3741.WILSON, C.A. & LEIGH, A.J. (1992) Endocrine toxicology of the

    Atterwill, C.K. and Flack, J. (eds),Endocrine Toxicology,pp. 3University Press.

    WONG, C.-C., DOHLER, K.-D., GEAELINGS, H. & VON ZUR M

    of age strain and season on circadian periodicity of pituitary go

  • 8/9/2019 Animal Clinical Chemistry

    140/231

    9Assessment of Gastrointestin

    and Pancreatic Toxic

    treatment groups and controls) as an indicator of gastrodi f f d d f d ddi i h f h li

    Assessment of gastrointestinal toxicity and pancrea

  • 8/9/2019 Animal Clinical Chemistry

    141/231

    studies of foods and food additives, much of the literatumalignant and vascular disease states, with relativemeasurements.

    It is generally thought that rodents and rabbits do not vprimates and cats do exhibit this reflex: when stimulated, fabsorption, toxicity and several biochemical measurements. gavage tube is correctly sited in the stomach, generally avoparticularly in rodents where regurgitation into the oesopharecognized that exposure by inhalation may result in second

    While aqueous vehicles such as water or saline may bematerials may be administered with other vehicles such as off i f i ifi i i

    Animal clinical chemistry 134

  • 8/9/2019 Animal Clinical Chemistry

    142/231

    9.2Carbohydrate and Lipid Metab

    Body glucose is mainly confined to the extracellular fluid wamounts in the liver and erythrocytes. Glucose enters nutritional sources or by hepatic glycogenolysis. Although constant in laboratory animals, it varies more than in man, maintaining glucose homeostasis removing approximately the portal circulation, and storing this as glycogen. In addi

    glycerol, pyruvate and alanineresulting from tissue meglucose by hepatic gluconeogenesis. Thus, it is predictabl

    been markedly altered. Blood collection procedures may l l h th i l i bj t t t i l

    Assessment of gastrointestinal toxicity and pancrea

  • 8/9/2019 Animal Clinical Chemistry

    143/231

    plasma glucose where the animal is subject to stress inclu1980).

    9.2.2Urine Glucose

    Test strips (or dipsticks) commonly used for urinary glglucose oxidase, and these yield semi-quantitative results; thby urinary ascorbate (see Chapter 3). Semi-quantitative mealkaline copper sulphate reagent, can be used to measure

    detect reducing substances other than glucose, e.g. fructose.to quantitative methods particularly for the detection of rena

    h in the mouse to 5 h in the dog. Urinary amylase is genel i i d b t it ff j di

    Animal clinical chemistry 136

  • 8/9/2019 Animal Clinical Chemistry

    144/231

    amylase is increased, but it offers no major diagnosmeasurements because it is also affected by renal injury and

    9.3.2Lipase

    Pancreatic lipase is secreted in its active form and this actand bile salts. Other lipasesphospholipase a, phospholihydrolaseare also secreted by the pancreas. Followingassays, plasma lipase measurements are being used in

    conjunction with plasma amylase can help diagnosis as pancreas (Banerjee et al.,1989). Some drugs, such as dexa

    Table 9.1 Examples of pancreatic

    Assessment of gastrointestinal toxicity and pancrea

  • 8/9/2019 Animal Clinical Chemistry

    145/231

    Table 9.1Examples of pancreatichormones

    Hormone and location FunctionGastric antrum and duodenum

    Gastrin (from G cells) Stimulates gastric H+secremucosa

    Duodenum and jejunum

    Secretin Stimulates pancreatic secrCholecystokinin (CCK) Stimulates secretion of pan

    (Koop et al., 1982; Larsson et al., 1986), and the peptidsample collection procedures with protease inhibitors

    Animal clinical chemistry 138

  • 8/9/2019 Animal Clinical Chemistry

    146/231

    sample collection procedures with protease inhibitors.

    9.5Other Tests of Gastrointestinal and Panc

    Pancreatic function tests include the use of synthetic peaminobenzoic acid (BT-PABA) tests, fluoroscein dilauratabsorption, and stimulation of pancreatic enzyme sepancreozymin (CCK-PZ) or the Lundh test meal. As the ex

    toxicity from oxygen free radicals, other measurements to radicals may be used in mechanistic studies (Braganza, 1

    References

    Assessment of gastrointestinal toxicity and pancrea

  • 8/9/2019 Animal Clinical Chemistry

    147/231

    ARGLEBE, C., BREMER, K. & CHILLA, R. (1978) Hyperamylasexperimental sialoadenosis in the rat.Archives of Oral Biology,

    AUNGST, B. & SHEN, D.D. (1986) In Rozman, K. & Hanninen, OToxicology,pp. 2955. Amstersdam: Elsevier Science.

    BANERJEE, A.K., PATEL, K.J. & GRAINGER, S.L. (1989) Drugcritical review.Medical Toxicology and Adverse Drug Experien

    BERTHET, J. (1963). Pancreatic hormones: glucagon . In von EuleComparative Endocrinology,pp. 41028. London: Academic P

    BOULAY, J.P., LIPOWITZ, A.J., KLAUSNER, J.S., ELLEFSON

    (1986) Evaluation of a fluorimetric method for the quantitative dog.American Journal of Veterinary Research,47,12935.BOYD E J S RINDERKNECHT H & WORMSLEY K G (198

    OMAYE, S.T. (1985) Effects of diet on toxicity testing. FederationPARENT, J. (1982) Effects of dexamethasone on pancreatic tissue

    Animal clinical chemistry 140

  • 8/9/2019 Animal Clinical Chemistry

    148/231

    PARENT, J. (1982) Effects of dexamethasone on pancreatic tissuelipase activities in dogs.Journal of the Veterinary Medical Asso

    RAJASINGHAM, R., BELL, J.L. & BARON, D.N. (1971) A com

    of mammalian alpha amylase.Enzyme,12,1806.SMITH, P.L. (1986) Gastrointestinal physiology. In Rozman, K. anGastrointestinal Toxicology.Amsterdam: Elsevier Science.

    SRINIVAS, M., GHOSH, K., SHOME, D.K., VIRDI, J.S., KUMAK.C. (1986) Glycosylated hemoglobin (HbA1) in normal rhesus

    Journal of Medical Primatology,15,3615.SZABO, S., SPILL, W.F. & RAINSFORD, K.D. (1989) Non-stero

    induced gastropathy. Mechanism and management.Medical ToExperience,4,7794.

    TANI S ISHIKAWA A YAMAZAKI H & KUDO Y (1987)

  • 8/9/2019 Animal Clinical Chemistry

    149/231

    10Assessment of Cardiotoxic

    Myotoxicity

    Table 10.1Plasma enzymes and th lf li (h) i t i ( ft

    Animal clinical chemistry 142

  • 8/9/2019 Animal Clinical Chemistry

    150/231

    half-lives (h) in two species (after

    1986)

    Enzyme Dog

    AST 3.3 to 4.4

    CK (total) 0.6 to 16.2

    CK-MB 1.3 to 8.1

    LDH (total) 1.6

    LDHH4 3 3

    isoenzymes are numbered according to decreasing anodic m

    separation: LDH1 has four H subunits LDH5 has four M su

    Assessment of cardiotoxicity and myotoxic

  • 8/9/2019 Animal Clinical Chemistry

    151/231

    separation: LDH1has four H subunits, LDH5has four M suLDH4 are hybrid combinationscontaining HHHM, HHM

    (Markert and Whitt, 1975). The widespread tissue distribu

    various species (Garbus et al.,1967; Ka